mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |